AstraZeneca (AZN)
(Delayed Data from NSDQ)
$77.34 USD
+0.54 (0.70%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $77.33 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AZN 77.34 +0.54(0.70%)
Will AZN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AZN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AZN
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
AZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Other News for AZN
TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form
AIM WINNERS & LOSERS: Aptamer rises on AstraZeneca contract
Aptamer shares jump as inks agreement with AstraZeneca
GLOBAL BROKER RATINGS: Redburn raises Siemens Energy to 'buy'
LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital